RNA-binding protein HuR and the members of the miR-200 family play an unconventional role in the regulation of c-Jun mRNA
- Giorgia Del Vecchio1,4,
- Francesca De Vito1,4,
- Sita J. Saunders2,
- Adele Risi1,
- Cecilia Mannironi3,
- Irene Bozzoni1 and
- Carlo Presutti1
- 1Dipartimento di Biologia e Biotecnologie, Università “Sapienza,” 00185 Rome, Italy
- 2Bioinformatics Group, Department of Computer Science, Albert-Ludwigs-University Freiburg, 79110 Freiburg, Germany
- 3IBPM–CNR, 00185 Rome, Italy
- Corresponding author: carlo.presutti{at}uniroma1.it
-
↵4 These authors contributed equally to this work.
Abstract
Post-transcriptional gene regulation is a fundamental step for coordinating cellular response in a variety of processes. RNA-binding proteins (RBPs) and microRNAs (miRNAs) are the most important factors responsible for this regulation. Here we report that different components of the miR-200 family are involved in c-Jun mRNA regulation with the opposite effect. While miR-200b inhibits c-Jun protein production, miR-200a tends to increase the JUN amount through a stabilization of its mRNA. This action is dependent on the presence of the RBP HuR that binds the 3′UTR of c-Jun mRNA in a region including the mir-200a binding site. The position of the binding site is fundamental; by mutating this site, we demonstrate that the effect is not micro-RNA specific. These results indicate that miR-200a triggers a microRNA-mediated stabilization of c-Jun mRNA, promoting the binding of HuR with c-Jun mRNA. This is the first example of a positive regulation exerted by a microRNA on an important oncogene in proliferating cells.
Keywords
Footnotes
-
Article published online ahead of print. Article and publication date are at http://www.rnajournal.org/cgi/doi/10.1261/rna.057588.116.
- Received May 19, 2016.
- Accepted May 27, 2016.
This article is distributed exclusively by the RNA Society for the first 12 months after the full-issue publication date (see http://rnajournal.cshlp.org/site/misc/terms.xhtml). After 12 months, it is available under a Creative Commons License (Attribution-NonCommercial 4.0 International), as described at http://creativecommons.org/licenses/by-nc/4.0/.










